Medicare rebate for Ambulatory BP Monitoring

Thursday, 09 July 2020 | Brooke Kenny

Clinpath Pathology are heartened by the news that the Medicare item for ambulatory BP monitoring has been given the green light

As reported by Siobhan Calafiore for the Australian Doctor Group, “GPs could soon access Medicare funding for ambulatory BP monitoring (ABPM), after the Federal Government's expert committee concluded the “gold standard” test was being underused because of cost.”

Controlling blood pressure is among the most important risk factors for reducing incident cardiovascular events. The blood pressure 24-hr monitors are designed to measure blood pressure at regular intervals throughout the day and night, with the device fitted and removed by appointment at the majority of our collection centres.

Clinpath Pathology continues to provides South Australian Doctors with state-of-the-art, innovative cardiac services such as the latest in Holter and cardiac reporting technology, inclusive of Ambulatory Blood Pressure Monitoring services.

At present, with no Medicare rebate available for Ambulatory Blood Pressure Monitoring the cost to the patient is $95 however if approved the cost of the test will be covered by the proposed MBS funding, meaning there will be no out of pocket expense to the patient, noting this test is only covered once per annum.

We welcome the announcement from Medicare and will release further information and advice once we have more information around the scheduled changes.

If you have any questions, you can also contact your Client Liaison representative to discuss. We encourage you to stay aware of our directives, either via this medium, your BD Client Liaison Rep, or our website here:

Kind regards,

Brooke Kenny

Pre-Analytics Manager



Full Article: